Recombinant Pseudomonas aeruginosa ATP synthase subunit alpha (atpA), partial

What is the role of ATP synthase alpha subunit in Pseudomonas aeruginosa pathogenicity?

ATP synthase in P. aeruginosa functions as a crucial membrane-bound enzyme complex that utilizes ATP hydrolysis for transporting protons across the bacterial membrane. Multiple studies have demonstrated that this enzyme is essential for maintaining viability, metabolic processes, and pathogenicity under various growth conditions . The alpha subunit (atpA) forms part of the F1 catalytic domain of ATP synthase and plays a critical role in ATP synthesis and hydrolysis.

Research has established that functional ATP synthase is necessary for P. aeruginosa growth and virulence expression. Inhibition of ATP synthase results in loss of pathogenicity, reduced motility, and attenuated biofilm formation . This connection between ATP synthase activity and virulence makes the alpha subunit a particularly interesting target for both basic research and therapeutic development.

How does P. aeruginosa ATP synthase alpha subunit differ from other bacterial species?

While ATP synthase is highly conserved across bacterial species, P. aeruginosa exhibits unique characteristics that distinguish it from other well-studied bacteria like Escherichia coli. Studies indicate that P. aeruginosa requires significantly higher levels of energy metabolism compared to E. coli, potentially reflecting its adaptation to diverse host environments .

The ATP synthase F1 α subunit in P. aeruginosa contains specific structural features that can potentially be targeted for selective inhibition. Unlike E. coli, P. aeruginosa possesses multiple biotinylated enzymes, including PA4847 (AccB, biotin carboxyl carrier protein), which may interact with energy metabolism pathways including those involving ATP synthase . This distinctive metabolic profile explains why P. aeruginosa might be particularly vulnerable to ATP synthase inhibition in certain physiological conditions.

What expression systems are most effective for producing recombinant P. aeruginosa ATP synthase alpha subunit?

Traditional E. coli expression systems often result in inclusion body formation when expressing membrane-associated proteins like ATP synthase subunits. An innovative alternative is using the P. aeruginosa type III secretion system (TTSS), which allows for the production of soluble secreted proteins .

The methodology involves:

• Construction of an expression vector (such as pEAI-S54) containing the atpA gene

• Transformation into a P. aeruginosa strain with deletions in genes coding for toxins (like CHA-OST strain)

• Induction of expression using an inducible promoter system

• Collection of secreted protein from the culture medium

This approach has shown success in producing active recombinant proteins from P. aeruginosa with proper folding and disulfide bonding, avoiding the common challenge of inclusion body formation . The table below summarizes the advantages of the P. aeruginosa TTSS system compared to traditional expression methods:

What are optimal conditions for purifying active recombinant P. aeruginosa ATP synthase alpha subunit?

Purification of recombinant P. aeruginosa ATP synthase alpha subunit requires careful optimization to maintain structural integrity and enzymatic activity. The most effective purification protocol involves:

• Expression in chemically defined media (such as RPMI) to minimize contaminants

• Concentration of the supernatant containing the secreted protein

• Affinity chromatography using engineered tags (His-tag is commonly employed)

• Size exclusion chromatography to ensure isolation of properly folded monomers

Research has demonstrated that using the CHA-OST strain of P. aeruginosa, which has deletions in genes coding for endogenous toxins, significantly increases the purity and yield of recombinant proteins in the supernatant . This strain modification reduces the presence of major protein contaminants that would otherwise complicate downstream purification processes.

What assays are recommended for measuring enzymatic activity of recombinant P. aeruginosa ATP synthase alpha subunit?

Several assay methods have been developed to assess the functionality of recombinant ATP synthase alpha subunit:

• ATP Hydrolysis Assay: Measures the rate of inorganic phosphate release using colorimetric detection (malachite green assay)

• ATP Synthesis Monitoring: Uses luciferase-based detection systems to quantify ATP production

• Proton Translocation Assays: Employs pH-sensitive fluorescent dyes to monitor proton movement across membranes

When establishing these assays, it's essential to account for the specific biochemical properties of P. aeruginosa ATP synthase. Research indicates that P. aeruginosa may require different ion concentrations and pH optima compared to model organisms like E. coli . Functional assays should incorporate appropriate controls to distinguish between specific inhibition of the alpha subunit versus other components of the ATP synthase complex.

How can researchers investigate the interaction between ATP synthase alpha subunit and potential inhibitors?

Investigation of inhibitor interactions with recombinant P. aeruginosa ATP synthase alpha subunit can be approached through multiple complementary techniques:

• Enzyme Inhibition Kinetics: Determine IC50 values and inhibition mechanisms (competitive, non-competitive, or uncompetitive)

• Thermal Shift Assays: Measure changes in protein thermal stability upon inhibitor binding

• Surface Plasmon Resonance: Quantify binding kinetics and affinity constants

• Structural Studies: X-ray crystallography or cryo-EM to visualize inhibitor binding sites

Recent studies have identified several compounds that inhibit P. aeruginosa ATP synthase, including C1/C2 quinoline analogues that were synthesized and evaluated for their ability to specifically target this enzyme . When designing inhibition experiments, researchers should consider the membrane-associated nature of the native ATP synthase complex and design assays that account for the protein's natural environment.

Why is P. aeruginosa ATP synthase considered a promising antimicrobial target?

P. aeruginosa ATP synthase has emerged as an attractive antimicrobial target for several compelling reasons:

• It is essential for bacterial viability and pathogenicity

• P. aeruginosa is a leading cause of resistant nosocomial infections worldwide

• Success of the anti-tuberculosis drug bedaquiline (which targets mycobacterial ATP synthase) demonstrates the viability of this approach

• ATP synthase inhibition can interfere with multiple aspects of bacterial physiology, including energy production and virulence factor expression

Research has shown that inhibition of ATP synthase in P. aeruginosa can lead to significant reductions in bacterial fitness and virulence. The alpha subunit, as part of the F1 catalytic domain, plays a critical role in the enzyme's function and presents specific structural features that can potentially be targeted by selective inhibitors .

What screening methods are most effective for identifying inhibitors of P. aeruginosa ATP synthase?

Researchers have developed several efficient screening approaches for identifying compounds that inhibit P. aeruginosa ATP synthase:

• High-throughput biochemical assays: Using purified recombinant protein to screen for direct inhibitors of enzymatic activity

• Whole-cell phenotypic screens: Identifying compounds that reduce bacterial viability with subsequent target validation

• In silico screening: Structure-based virtual screening using computational models of the ATP synthase alpha subunit

• Repurposing screens: Testing known ATP synthase inhibitors from other species for activity against P. aeruginosa

Recent work has identified six compounds from a series of C1/C2 quinoline analogues that demonstrate inhibitory activity against P. aeruginosa ATP synthase and antibacterial effects against wild-type P. aeruginosa . These findings highlight the potential of ATP synthase as a druggable target and provide starting points for further optimization of selective inhibitors.

What is the relationship between ATP synthase and antimicrobial peptide resistance in P. aeruginosa?

Proteomic studies have revealed intriguing connections between ATP synthase and antimicrobial peptide (AMP) responses in P. aeruginosa. When exposed to certain AMPs, P. aeruginosa exhibits differential expression of proteins involved in energy metabolism, particularly ATP synthase components:

• Recombinant AMPs defensin-d2 and actifensin induce downregulation of ATP synthase F1 α subunit within 1 hour of treatment

• This downregulation correlates with significant reductions in bacterial viability

• Concurrent changes occur in proteins related to ion transport, homeostasis, and structural biogenesis

The table below summarizes the proteomic changes observed in P. aeruginosa following treatment with different antimicrobial peptides:

These findings suggest that ATP synthase inhibition may be a common mechanism through which certain AMPs exert their antimicrobial effects against P. aeruginosa . Understanding this relationship could inform the development of combination therapies that target both ATP synthase and other cellular processes to overcome antimicrobial resistance.

How can structural biology approaches enhance ATP synthase inhibitor development?

Advanced structural biology techniques offer powerful tools for rational design of selective inhibitors against P. aeruginosa ATP synthase:

• Cryo-electron microscopy: Provides high-resolution structures of the entire ATP synthase complex in different conformational states

• X-ray crystallography: Offers atomic-level details of the alpha subunit's active site and potential binding pockets

• Molecular dynamics simulations: Helps understand protein flexibility and inhibitor interactions in a dynamic context

• Hydrogen-deuterium exchange mass spectrometry: Identifies regions of conformational change upon inhibitor binding

These techniques can reveal specific structural features of the P. aeruginosa ATP synthase alpha subunit that differ from human homologs, enabling the design of selective inhibitors with reduced off-target effects. Additionally, understanding the structural basis for existing ATP synthase inhibitors, such as the quinoline analogues described in recent research , can guide optimization efforts to improve potency and selectivity.

What emerging technologies might enhance our understanding of ATP synthase function in P. aeruginosa?

Several cutting-edge technologies are poised to advance research on P. aeruginosa ATP synthase:

• CRISPR interference (CRISPRi): Allows precise downregulation of atpA expression to study gene dosage effects

• Live-cell imaging: Enables visualization of ATP synthase dynamics within bacterial cells

• Nanodiscs and lipid bilayer systems: Provides native-like membrane environments for functional studies

• Single-molecule techniques: Offers insights into the rotary mechanism of ATP synthase at unprecedented resolution

These approaches will help address outstanding questions about how ATP synthase contributes to P. aeruginosa adaptability across different environmental conditions and infection settings. Furthermore, integrating these technologies with systems biology approaches will provide a more comprehensive understanding of how ATP synthase inhibition affects global cellular processes.

How might combination therapies targeting ATP synthase overcome resistance mechanisms in P. aeruginosa?

P. aeruginosa is notorious for developing resistance to antibiotics through multiple mechanisms. Strategic combination therapies targeting ATP synthase could potentially overcome these resistance mechanisms:

• Dual-targeting approaches: Combining ATP synthase inhibitors with drugs that target other essential processes

• Efflux pump inhibitors: Pairing ATP synthase inhibitors with compounds that block efflux pumps to maintain intracellular drug concentrations

• Biofilm disruptors: Combining ATP synthase inhibitors with agents that penetrate or disrupt biofilms

• Virulence attenuators: Pairing ATP synthase inhibitors with compounds that target virulence factor production

Research has shown that ATP synthase inhibition can affect multiple cellular processes in P. aeruginosa, including energy production and virulence factor expression . By exploiting these pleiotropic effects through rationally designed combination therapies, researchers may develop more effective strategies to combat multidrug-resistant P. aeruginosa infections.